Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
2019 · Science Translational Medicine · 205 citations
https://doi.org/10.1126/scitranslmed.aav0891
V
Verena Sailer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
1.3K
Citations
19
h-index
24
i10-index
Verena Sailer is an academic researcher from University Hospital Schleswig-Holstein. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Radiopharmaceutical Chemistry and Applications & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 19, co-authored 62 publications.
ORCID: 0000-0003-3647-2213Papers by this author
worksPITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
2016 · Clinical Epigenetics · 21 citations
https://doi.org/10.1186/s13148-016-0270-x
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer
2023 · Cancer Research Communications · 7 citations
https://doi.org/10.1158/2767-9764.crc-22-0491
High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial
2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 7 citations
https://doi.org/10.1007/s00428-024-03999-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat